Systematic Financial Management LP Purchases 13885 Shares of Gilead Sciences (NASDAQ:GILD)

The institutional investor held 129,752 shares of the health care company at the end of 2017Q4, valued at $9.30 million, up from 66,656 at the end of the previous reported quarter. (NASDAQ:GILD) stock has decreased in price by 2.63%. About 2.10M shares traded. It has underperformed by 69.26% the S&P500.

Meyer Handelman Co decreased Gilead Sciences Inc (GILD) stake by 29.46% reported in 2017Q4 SEC filing. Tb Alternative Assets Ltd bought 91,600 shares as the company's stock rose 1.93% while stock markets declined. Van Cleef Asset Managementinc who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $95.72B market cap company. The stock increased 2.06% or $1.5086 during the last trading session, reaching $74.9186. It also reduced its holding in First Tr Exch Traded Fd Iii Ho by 37,049 shares in the quarter, leaving it with 20,597 shares, and cut its stake in Ssga Active Etf Tr Spdr Tr Tac. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 14, 2017 and is uptrending. It has underperformed by 24.13% the S&P500. Lazard Asset Llc holds 1.47% or 9.10 million shares. (NASDAQ:ULTI). Parametric Port Assocs Ltd Liability Corp stated it has 0.01% of its portfolio in The Ultimate Software Group, Inc.

Investors sentiment increased to 1.06 in Q4 2017. Its down 0.06, from 0.83 in 2017Q3. 95 funds opened positions while 250 raised stakes. Jarislowsky Fraser reported 2.59 million shares. Gilead Sciences Inc now has $97.68 billion valuation. Goldstein Munger & Associates reported 236 shares or 0.12% of all its holdings. Kentucky Retirement System holds 0.12% or 9,621 shares in its portfolio. Bessemer holds 0.01% or 40,033 shares in its portfolio. King Wealth Ltd owns 31,193 shares or 0.94% of their U.S. portfolio. (NYSEAMERICAN:GSAT). 57.17 million are owned by Vanguard Gru. Texas Permanent School Fund has invested 0.45% in International Business Machines Corporation (NYSE:IBM). (NASDAQ:GILD). Ashfield Cap Ptnrs Ltd stated it has 2,820 shares. 47,500 were reported by Clarkston Cap Lc. Optimum Investment Advsrs holds 1.43% or 62,662 shares. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company. Therefore 56% are positive. On Wednesday, February 7 the stock of Gilead Sciences, Inc. Cowen & Co maintained Microsoft Corporation (NASDAQ:MSFT) rating on Wednesday, June 14. (NASDAQ:GILD) has "Outperform" rating given on Wednesday, March 23 by Credit Suisse. Gilead Sciences has a 12-month low of $70.83 and a 12-month high of $103.55. (NASDAQ:GILD) has "Equal-Weight" rating given on Friday, October 6 by Morgan Stanley. The firm has "Outperform" rating given on Tuesday, January 16 by Wells Fargo. (NASDAQ:GILD) has 29 ratings reports on April 9, 2018 according to StockzIntelligence. On Thursday, December 21 the rating was maintained by Oppenheimer with "Hold". On Thursday, October 5 the stock rating was maintained by Leerink Swann with "Market Perform". Argus Research maintained the stock with "Buy" rating in Wednesday, March 22 report. As per Wednesday, December 16, the company rating was maintained by Deutsche Bank. (NASDAQ:GILD) has "Buy" rating given on Tuesday, July 25 by Cowen & Co.

Investors sentiment decreased to 0.8 in Q4 2017. It has 0.23, from change from 2017Q3's 1.03.

Several other hedge funds and other institutional investors also recently modified their holdings of GILD. 134 funds opened positions while 676 raised stakes. 280.02 million shares or 0.09% more from 279.77 million shares in 2017Q3 were reported. Nomura maintained Microsoft Corporation (NASDAQ:MSFT) on Friday, October 21 with "Buy" rating. (NASDAQ:GILD). Bb&T Secs Lc has 199,159 shs. Loomis Sayles And Com Lp holds 0% or 161 shares in its portfolio. The Company focuses on the discovery, development and commercialization of medicines in areas of unmet medical need. (NASDAQ:GILD). Ariel Investments Ltd Liability Corp invested in 1.81% or 2.24 million shares. State Of Alaska Department Of Revenue reported 128,498 shares. Girard Prns Limited accumulated 21,504 shares. Hodges Capital Mgmt Inc reported 0.09% of its capital in Gilead Sciences, Inc. 50,000 shares valued at $3.68M were sold by MARTIN JOHN C on Tuesday, January 2. Richard Bernstein Advsr Limited has 0% invested in Gilead Sciences, Inc. This target is 6.72 % from GILD's current share price. Company insiders own 1.16% of the company's stock. Liberty Mutual Group Inc Asset Mngmt Inc accumulated 52,049 shares or 0.11% of the stock. Following a recent spotcheck, the public organization Gilead Sciences, Inc. Following the completion of the sale, the chairman now directly owns 3,046,766 shares in the company, valued at $254,587,766.96. Redwood Investments Limited Com holds 86,323 shs. (NYSE:CMI). Bnp Paribas Arbitrage holds 0.02% or 82,175 shares.

Since January 2, 2018, it had 0 insider purchases, and 14 sales for $34.98 million activity. USA oil stocks fell 2.3% on fears Beijing could restrict crude exports.

In related news, CFO Robin L. Washington sold 5,000 shares of the firm's stock in a transaction dated Wednesday, February 28th. Another trade for 100,000 shares valued at $8.02 million was sold by Meyers James R. On Friday, February 9 the insider WILSON GAYLE E sold $4.68M. (NASDAQ:ULTI). Invesco Ltd invested in 0.03% or 336,735 shares. The Return on Assets (ROA) ratio, on the other hand, shows how profitable an organization is relative to its total assets owned. The shares were sold at an average price of $77.63, for a total value of $7,763,000.00.

Latest News